Benefit of Anticoagulation Therapy in Hyperthyroidism‐Related Atrial Fibrillation
ConclusionsPatients with hyperthyroidism‐related AF are at high risk of stroke (3.9% per year). Warfarin confers stroke prevention in patients with CHA2DS2‐VASc ≥1 and non–self‐limiting AF. Overall stroke risk was lower in hyperthyroid non–self‐limiting AF patients compared with nonhyperthyroid counterparts.
Source: Clinical Cardiology - Category: Cardiology Authors: Pak‐Hei Chan, Jojo Hai, Chun‐Yip Yeung, Gregory Y.H. Lip, Karen Siu‐Ling Lam, Hung‐Fat Tse, Chung‐Wah Siu Tags: Clinical Investigations Source Type: research
More News: Aspirin | Atrial Fibrillation | Cardiology | Coumadin | Heart | Hemorrhagic Stroke | Hyperthyroidism | Ischemic Stroke | Stroke | Study | Warfarin